RecruitingNCT06627933
Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement
Sponsor
I.M. Sechenov First Moscow State Medical University
Enrollment
1,000 participants
Start Date
Jan 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb joint replacement, the influence of known risk factors and strategies for perioperative prevention of thromboembolic complications on the frequency of cardiovascular complications and to develop approaches to optimize antithrombotic prevention tactics.
Eligibility
Min Age: 18 YearsMax Age: 95 Years
Inclusion Criteria4
- Informed consent
- Age older than 18 y.o.
- Cardiovascular disease
- Indications for planned lower limb joint replacement surgery
Exclusion Criteria4
- Pregnancy
- Psychiatric disorders
- Decompensated heart failure or acute heart failure
- Known diagnosis of cancer
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNo intervention
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06627933
Related Trials
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NCT053013481 location
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
NCT0425848815 locations
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT0426303839 locations
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
NCT0385559248 locations
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
NCT066579241 location